SCHEMBL7219919

SCHEMBL7219919

CCc1cccc2c(O)cc(C(F)(F)F)nc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.42
GABRB2 P47870 1/20 0.42
KCNH2 Q12809 6/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CYP2D6 P10635 3/20 0.38
ELANE P08246 1/20 0.37
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 2/20 0.37
CYP1A2 P05177 2/20 0.37
TSHR P16473 2/20 0.37
CYP2C19 P33261 2/20 0.37
MAPT P10636 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
DAO P14920 2/20 0.36
DDO Q99489 1/20 0.36
ADORA2A P29274 5/20 0.36
ADORA1 P30542 5/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7220879 0.82 MEN1 (0.39) GABRA1GABRB2KCNH2MEN1KMT2A
SCHEMBL1655812 0.81 KCNH2 (0.49) KCNH2CYP2D6ALDH1A1KDM4ECYP1A2
SCHEMBL7691626 0.81 PARP1 (0.43) KCNH2CYP2D6KDM4ECYP1A2TSHR
SCHEMBL2709066 0.80 ELANE (0.47) KCNH2MEN1KMT2ACYP2D6ELANE
SCHEMBL2709776 0.78 PRKD3 (0.40) KCNH2CYP2D6KDM4ECYP1A2TSHR
SCHEMBL28858276 0.77 ENPP3 (0.48) KCNH2MEN1KMT2ACYP2D6KDM4E
SCHEMBL2711485 0.77 MAP4K4 (0.41) KCNH2MEN1KMT2ACYP2D6ALDH1A1
SCHEMBL31327745 0.77 ENPP3 (0.48) KCNH2MEN1KMT2ACYP2D6KDM4E
SCHEMBL7234880 0.77 ADORA2A (0.63) KCNH2MEN1KMT2ACYP2D6ALDH1A1
SCHEMBL2709144 0.77 TNKS (0.44) MEN1KMT2AALDH1A1KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583156-B1 Particularly adenosine A2A receptors; neurodegenerative disorders; 2,8-bis(trifluoromethyl)-alpha -(3-thienyl)-4-quinolinemethanol VERNALIS RESEARCH LIMITED (GB) 2003-06-24 US disclosed
EP-1107760-A2 4-QUINOLINEMETHANOL DERIVATIVES AS PURINE RECEPTOR ANTAGONISTS (I) VERNALIS RESEARCH LIMITED (GB) 2001-06-20 EP disclosed
WO-2000013681-A2 4-QUINOLINEMETHANOL DERIVATIVES AS PURINE RECEPTOR ANTAGONISTS (I) VERNALIS RESEARCH LIMITED (GB) 2000-03-16 WO disclosed